Rampant Increase in Cases of Mucormycosis in India and Pakistan : A Serious Cause for Concern during the Ongoing COVID-19 Pandemic

COVID-19 is a global health crisis that continues to pose new challenges all around the world. Amidst the growing pandemic, a spike in the number of mucormycosis cases in India and Pakistan has been reported in COVID-19 patients and in those who have recovered from COVID-19. This increase in cases may be related to the overuse of steroids and zinc, the use of industrial oxygen, unsterilized medical equipment, frequent intubation, a weakened immune system, and pre-existing comorbidities such as diabetes. As a result, it is critical to take steps to handle the current increase in mucormycosis cases. Therefore, this article aims to highlight the existence of mucormycosis amidst the COVID-19 pandemic in India and Pakistan, focusing on possible causes and implications, and suggests important plans of action to be taken during this pandemic.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:105

Enthalten in:

The American journal of tropical medicine and hygiene - 105(2021), 5 vom: 30. Aug., Seite 1144-1147

Sprache:

Englisch

Beteiligte Personen:

Ghazi, Behram Khan [VerfasserIn]
Rackimuthu, Sudhan [VerfasserIn]
Wara, Um Ul [VerfasserIn]
Mohan, Anmol [VerfasserIn]
Khawaja, Uzzam Ahmed [VerfasserIn]
Ahmad, Shkaib [VerfasserIn]
Ahmad, Shahzaib [VerfasserIn]
Hasan, Mohammad Mehedi [VerfasserIn]
Dos Santos Costa, Ana Carla [VerfasserIn]
Ahmad, Shoaib [VerfasserIn]
Essar, Mohammad Yasir [VerfasserIn]

Links:

Volltext

Themen:

Antifungal Agents
Journal Article

Anmerkungen:

Date Completed 28.12.2021

Date Revised 28.12.2021

published: Electronic

Citation Status MEDLINE

doi:

10.4269/ajtmh.21-0608

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330031953